Omburtamab Uses, Dosage, Side Effects and more
Omburtamab is under investigation in clinical trial NCT03275402 (131i-omburtamab Radioimmunotherapy for Neuroblastoma Central Nervous System/leptomeningeal Metastases).
| Trade Name | Omburtamab |
| Generic | Omburtamab |
| Omburtamab Other Names | Omburtamab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
